-+ 0.00%
-+ 0.00%
-+ 0.00%

*Entrada Therapeutics: On Track to Report ELEVATE-44-201 Data From Cohort 1 in Q2 2026 and Cohort 2 by Yr-end 2026 >TRDA

Dow Jones·02/26/2026 12:19:00

Please log in to view news